Amyloid‐β oligomers in cellular models of Alzheimer's disease - Fontana - 2020 - Journal of Neurochemistry - Wiley Online Library
ADPD 2023: Alzheimer's Disease Therapeutics, Diagnostics & Mechanisms
Association of B cell profile and receptor repertoire with the progression of Alzheimer's disease - ScienceDirect
Frontiers | Manipulation of the diet–microbiota–brain axis in Alzheimer's disease
An App knock-in rat model for Alzheimer's disease exhibiting Aβ and tau pathologies, neuronal death and cognitive impairments | Cell Research
Pyroglutamate Aβ cascade as drug target in Alzheimer's disease | Molecular Psychiatry
Pro-inflammatory interleukin-6 signaling links cognitive impairments and peripheral metabolic alterations in Alzheimer's disease | Translational Psychiatry
The Amyloid-β Pathway in Alzheimer's Disease | Molecular Psychiatry
Advances in the development of new biomarkers for Alzheimer's disease | Translational Neurodegeneration | Full Text
Identifying and validating biomarkers for Alzheimer's disease: Trends in Biotechnology
JCM | Free Full-Text | Investigating the Prognostic Role of Peripheral Inflammatory Markers in Mild Cognitive Impairment
Amyloid-β (Aβ) marker expression and Aβ aggregation in the... | Download Scientific Diagram
Blood‐based biomarkers for Alzheimer's disease | EMBO Molecular Medicine
Alteration of mTOR signaling occurs early in the progression of Alzheimer disease (AD): analysis of brain from subjects with pre‐clinical AD, amnestic mild cognitive impairment and late‐stage AD - Tramutola - 2015 -
JPM | Free Full-Text | Current Biomarkers for Alzheimer's Disease: From CSF to Blood
New Alzheimer's Biomarkers may Support Early Diagnosis
Past, present and future of therapeutic strategies against amyloid-β peptides in Alzheimer's disease: a systematic review - ScienceDirect
Comprehensive Review of Nutraceuticals against Cognitive Decline Associated with Alzheimer's Disease | ACS Omega
Isoorientin Affects Markers of Alzheimer's Disease via Effects on the Oral and Gut Microbiota in APP/PS1 Mice - The Journal of Nutrition
Cerebrospinal fluid p-tau231 as an early indicator of emerging pathology in Alzheimer's disease - eBioMedicine
Frontiers | Alzheimer's disease: a mini-review for the clinician
Decreased salivary lactoferrin levels are specific to Alzheimer's disease - eBioMedicine
Fc effector of anti-Aβ antibody induces synapse loss and cognitive deficits in Alzheimer's disease-like mouse model | Signal Transduction and Targeted Therapy
